FocusLeishmaniasis

Using Humans to Make a Human Leishmaniasis Vaccine

Science Translational Medicine  30 Apr 2014:
Vol. 6, Issue 234, pp. 234fs18
DOI: 10.1126/scitranslmed.3009118

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

The cellular immune response to peptide pools from conserved Leishmania antigens in leishmaniasis-immune individuals identified epitopes for a human DNA vaccine (Das et al., this issue).

View Full Text

Related Content